Daniel Peel

Daniel Peel is a seasoned Clinical Trial Professional with extensive experience in clinical trial management, TMF processes, and quality control across multiple organizations, including Incyte, Daiichi Sankyo, and Biogen. At Incyte since January 2018, Daniel has been instrumental in developing the TMF Pilot Program, creating management plans, and implementing quality control measures for TMF documents. Previous roles include serving as a TMF Specialist at Daiichi Sankyo and Clinical Trial Specialist at Biogen, where Daniel showcased expertise in document reconciliation, quality checking, and regulatory compliance. With a B.A. in Anthropology from Oberlin College and Lean Six Sigma certification from Villanova University, Daniel is skilled in process improvement and efficient trial management.